TAKANORI TAOGOSHI

Last Updated :2025/06/04

Affiliations, Positions
Hiroshima University Hospital, Assistant Professor

Basic Information

Academic Degrees

  • Doctor of Philosophy in Pharmaceutical Science, Hiroshima University
  • Master of Pharmaceutical Science, Hiroshima University

Research Fields

  • Medicine,dentistry, and pharmacy;Pharmacy;Medical pharmacy

Research Keywords

  • pharmacokinetics
  • drug administration plan

Educational Activity

Course in Charge

  1. 2025, Undergraduate Education, 2Term, Clinical Pharmacy
  2. 2025, Undergraduate Education, 3Term, Clinical Medicine and Pharmacotherapy II
  3. 2025, Undergraduate Education, 3Term, Japanese Pharmacopoeia
  4. 2025, Undergraduate Education, Year, Special laboratory Works in Pharmaceutical Sciences I
  5. 2025, Undergraduate Education, Year, Special laboratory Works in Pharmaceutical Sciences II
  6. 2025, Undergraduate Education, Year, Special laboratory Works in Clinical Pharmacy I
  7. 2025, Undergraduate Education, Year, Special laboratory Works in Clinical Pharmacy II
  8. 2025, Undergraduate Education, Year, Special laboratory Works in Clinical Pharmacy III
  9. 2025, Graduate Education (Doctoral Program) , 4Term, Pharmacotherapeutic Research
  10. 2025, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Pharmaceutical Services
  11. 2025, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Pharmaceutical Services
  12. 2025, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Pharmaceutical Services
  13. 2025, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Pharmaceutical Services

Research Activities

Academic Papers

  1. Extravasation of Noncytotoxic Agents: Skin Injury and Risk Classification, Biol. Pharm. Bull., 46(6), 746-755, 20230601
  2. Classification of skin injury risk caused by extravasation of electrolyte solutions or infusions in a rat model, Biol. Pharm. Bull., 45(9), 1254-1258, 20220901
  3. A novel detection method for cross-linking of IgE-receptors by autoantibodies in chronic spontaneous urticaria, Allergol. Int., 71(1), 94-102, 20210828
  4. Identification of allergens for food-dependent exercise-induced anaphylaxis to shrimp, SCIENTIFIC REPORTS, 11(1), 20210308
  5. A novel test for type-I allergy based on crosslink formation of immunoglobulin-E receptors by allergen-specific immunoglobulin-E antibodies and an allergen, SCIENTIFIC REPORTS, 13(1), 19676, 202311
  6. Aspirin enhances sensitization to the egg-white allergen ovalbumin in rats, PLOS ONE, 14(12), 20191205
  7. Blockade of multiple monoamines receptors reduce insulin secretion from pancreatic beta-cells, SCIENTIFIC REPORTS, 9, 20191111
  8. Characterization of prostaglandin E1 transport in rat renal brush-border membrane., Drug Metab Pharmacokinet, 21(3), 186-193, 20060601
  9. Hypoallergenic Wheat Line (1BS-18H) Lacking omega 5-Gliadin Induces Oral Tolerance to Wheat Gluten Proteins in a Rat Model of Wheat Allergy, FOODS, 11(15), 202208
  10. Low Serum Albumin Level Is a Risk Factor for Delayed Methotrexate Elimination in High-Dose Methotrexate Treatment, ANNALS OF PHARMACOTHERAPY, 55(10), 1195-1202, 202110
  11. Vitamin A-coupled liposomal Rho-kinase inhibitor ameliorates liver fibrosis without systemic adverse effects, HEPATOLOGY RESEARCH, 49(6), 663-675, 201906
  12. Intestinal absorption of the wheat allergen gliadin in rats, ALLERGOLOGY INTERNATIONAL, 68(2), 247-253, 201904
  13. Comparison of Pegfilgrastim and Filgrastim for the Primary Prophylactic Effect for Preventing Febrile Neutropenia in Patients Undergoing Rituximab with Dose-adjusted EPOCH Chemotherapy, YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 139(4), 629-633, 201904
  14. Safety of Y-90-ibritumomab Tiuxetan Treatment for Japanese Patients in Real-world Clinical Practice, YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 139(1), 131-134, 201901
  15. Evaluation of Risk of Injury by Extravasation of Hyperosmolar and Vasopressor Agents in a Rat Model, BIOLOGICAL & PHARMACEUTICAL BULLETIN, 41(6), 951-956, 201806
  16. Stability of Adrenaline in Irrigating Solution for Intraocular Surgery, BIOLOGICAL & PHARMACEUTICAL BULLETIN, 39(5), 879-882, 201605
  17. Common food allergens and their IgE-binding epitopes, ALLERGOLOGY INTERNATIONAL, 64(4), 332-343, 201510
  18. Evaluation of corneal damage caused by iodine preparations using human corneal epithelial cells, JAPANESE JOURNAL OF OPHTHALMOLOGY, 58(6), 522-527, 201411
  19. Partial characterization of proapoptotic action of biliary deteriorated lipids on biliary epithelial cells in pancreaticobiliary diseases, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 21(3), 212-218, 201403
  20. The Mechanisms of Insulin Secretion and Calcium Signaling in Pancreatic beta-Cells Exposed to Fluoroquinolones, BIOLOGICAL & PHARMACEUTICAL BULLETIN, 36(1), 31-35, 201301
  21. Effects of 3-O-Methyldopa, L-3,4-Dihydroxyphenylalanine Metabolite, on Locomotor Activity and Dopamine Turnover in Rats, BIOLOGICAL & PHARMACEUTICAL BULLETIN, 35(8), 1244-1248, 201208
  22. Transport of prostaglandin E-1 across rat erythrocyte membrane, BIOLOGICAL & PHARMACEUTICAL BULLETIN, 31(6), 1288-1291, 200806
  23. Transport of prostaglandin E-1 across the blood-brain barrier in rats, JOURNAL OF PHARMACY AND PHARMACOLOGY, 57(1), 61-66, 200501
  24. Evaluation of the allergenicity of omega5-gliadin-deficient Hokushin wheat (1BS-18) in a wheat allergy rat model, Biochemistry and biophysics reports, 2019
  25. Injury due to extravasation of thiopental and propofol: Risks/effects of local cooling/warming in rats., Biochem. Biophys. Rep., 8, 207-211, 2016
  26. Characterization of prostaglandin E-1 transport in rat renal brush-border membrane, DRUG METABOLISM AND PHARMACOKINETICS, 21(3), 186-193, 2006

Invited Lecture, Oral Presentation, Poster Presentation

  1. Therapeutic drug monitoring in Hiroshima University Hospital and research for clinical application, Takanori Taogoshi, 2023 Forbidden City International Pharmacist Conference, 2023/07/07, With Invitation, English
  2. Initial Teicoplanin Dosing for Patients with Mild Renal Dysfunction, Hiyama Y, Kataoka T, Tomita T, Miyamoto K, Taogoshi T, Matsuo H, Hiyama Y, Kataoka T, Tomita T, Miyamoto K, Taogoshi T, Matsuo H, The 21st Asian Conference on Clinical Pharmacy: ACCP 2022 in Nagoya, 2022/02/11, Without Invitation, English, web
  3. Classification of Skin Injury Risk Caused by Extravasation of Electrolyte Solutions in a Rat Model, Taogoshi T, Shibata Y, Uno H, Yokooji T, Tanaka M, Hide M, Matsuo H, Taogoshi T, Shibata Y, Uno H, Yokooji T, Tanaka M, Hide M, Matsuo H, The 21st Asian Conference on Clinical Pharmacy: ACCP 2022 in Nagoya, 2022/02/11, Without Invitation, English, web
  4. Effects of non-steroidal anti-inflammatory drugs on sensitization to the egg-white allergen ovalbumin in rats, Fukushima T, Yokooji T, Hirano T, Kataoka Y, Taogoshi T, Matsuo H, JSA/WAO Joint Congress 2020, 2020/09/17, Without Invitation, English, Kyoto
  5. Evaluation of the allergenicity and induction ability for oral tolerance of omega 5-gliadin-deficient Hokushin wheat (1BS-18) in a wheat allergy rat model, Yamada Y, Yokooji T, Ninomiya N, Taogoshi T, Morita E, Matsuo M, JSA/WAO Joint Congress 2020, 2020/09/17, Without Invitation, English, Kyoto
  6. Safety of 90Y-ibritumomab tiuxetan treatment in Japanese patients in clinical practice, Hiroshi Yoshikawa, Hiroshi Sakurashita, Takanori Taogoshi, Hiroaki Matsuo, The 54rd ASHP Midyear Clinical Meeting & Exhibition, 2019/12/08, Without Invitation, English, ASHP, Las Vegas, Nevada
  7. Comparison of pegfilgrastim and filgrastim for the prophylactic effect for preventing febrile neutropenia in patients undergoing rituximab with etoposide, prednisolone, vincristine, cyclophosphamide and doxorubicin treatment, Takanori Taogoshi, Tatsuo Kataoka, Hiroshi Sakurashita, Hiroaki Matsuo, The 53rd ASHP Midyear Clinical Meeting & Exhibition, 2018/12/02, Without Invitation, English, ASHP, Anaheim, California
  8. Olanzapine suppresses insulin secretion from pancreatic beta-cells via blockade of multiple receptors, Mao Nagata, Tomoe Nakai, Yumika Miura, Takashi Tomita, Takanori Taogoshi, Tomoharu Yokooji, Yumi Sugimoto, Hiroaki Matsuo, 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences, 2018/09/02, Without Invitation, English, FIP, Glasgow, Scotland
  9. Enhancing effect of aspirin on intestinal absorption of gliadin, wheat allergen, and its mechanism, Tomoharu Yokooji, Koh Hamura, Naoki Ninomiya, Takanori Taogoshi, Hiroaki Matsuo, 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences, 2018/09/02, Without Invitation, English, FIP, Glasgow, Scotland
  10. Evaluation of risk for injury by extravasation of vasopressor and hyperosmolar agents in a rat model, Shibata Y, Sagara Y, Taogoshi T, Yokooji T, Hiroaki Matsuo, 18th World Congress of Basic and Clinical Pharmacology, 2018/07/01, Without Invitation, English, Kyoto
  11. Variable factors influencing the area under the concentration-time curve after administration busulfan in pediatric patients receiving a hematopoietic stem cell transplant conditioning regimen, Takanori Taogoshi, Aoi Nakano, Hiroshi Kawaguchi, Masao Kobayashi, Hiroaki Matsuo, The 52nd ASHP Midyear Clinical Meeting & Exhibition, 2017/12/05, Without Invitation, English
  12. Educational program for foreign pharmacists and international exchange students, Takanori Taogoshi, World Health Summit in Hiroshima 2017, 2017/10/07, With Invitation, English, Hiroshima